Market Overview:
The global drug delivery technologies market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in drug delivery technologies. Based on type, the oral drug delivery segment is expected to account for the largest share of the global drug delivery technologies market in 2018. This segment is projected to grow at a CAGR of 11.1% during the forecast period from 2018 to 2030. Oral drug delivery offers several advantages over other modes of administration such as ease-of-use and patient compliance due to its convenience and noninvasive nature. Based on application, hospitals are expected to account for the largest share of the global Drug Delivery Technologies Market in 2018 followed by home care settings and clinics respectively .
Product Definition:
Drug delivery technology is the use of various technologies to improve drug absorption, distribution, metabolism and excretion. By improving these factors, drug delivery technology can help reduce side effects and improve treatment outcomes. The importance of drug delivery technology is evident in the billions of dollars spent on developing new drugs each year. Improved drug delivery can help reduce development costs and increase the number of potential drugs that are brought to market.
Oral Drug Delivery:
Oral drug delivery is a process of delivering drugs to patients without the help of injections. The oral route of drug administration is the most widely used route in pharmaceutical products. It includes self-administration by patients and therapeutic applications such as tablets, capsules, lozenges, gels and syrups.
Pulmonary Drug Delivery:
Pulmonary drug delivery is the process of transporting drugs to the lungs. Pulmonary drug delivery technology market is segmented into two types on the basis of product and application. On the basis of products, it includes nebulizer, metered dose inhaler (MDI), dry powder inhaler (DPI), and liquid aerosol spray.
Application Insights:
Based on application, the global market is segmented into hospitals, home care settings, clinics, diagnostic centers and other. Hospitals held the largest share in 2017 owing to factors such as increasing prevalence of chronic diseases and growing geriatric population. Moreover, an increase in hospital-acquired infections due to central venous catheters has increased the demand for drug delivery devices in recent years.
The home care setting segment is expected to witness significant growth over the forecast period due to rising awareness about minimally invasive procedures and technological advancements that have made it easier for patients suffering from mobility disabilities or respiratory problems to access drugs through nasal sprays or inhalers without visiting a doctor's office or hospital room.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position during the forecast period. The growth of this region can be attributed to rising product approvals, increasing R&D investments by companies, and growing demand for efficient treatment options. China is one of the largest markets for these products due to a large population base suffering from chronic diseases such as diabetes & cancer. In addition, factors such as favorable government initiatives pertaining towards drug delivery technologies are also contributing towards regional growth.
The Asia Pacific market was followed by North America owing to high unmet medical needs coupled with constantly improving healthcare infrastructure in this region resulting into increased adoption rate of novel drug delivery systems across various applications including home care settings, clinics & hospitals etc.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The rise in the number of chronic diseases has led to an increase in the demand for drug delivery technologies that can help improve patient compliance and treatment outcomes.
- Growing demand for targeted drug delivery systems: Drug delivery technologies that can target specific tissues or organs are gaining popularity due to their ability to improve treatment outcomes and reduce side effects. There is a growing demand for such targeted drug delivery systems, especially in cases where traditional therapies have failed to provide satisfactory results.
- Advances in nanotechnology: Nanotechnology-based drug delivery systems are becoming increasingly popular due to their ability to deliver drugs directly to the site of action, thus reducing systemic exposure and minimizing adverse effects. These advanced nanotechnologies are also helping researchers develop new ways to administer existing drugs as well as novel therapeutics that were not previously possible using traditional methods alone.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Delivery Technologies Market Research Report
By Type
Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery
By Application
Hospitals, Home Care Settings, Clinics, Diagnostic Centres, Other
By Companies
Johnson & Johnson Services, Novartis, Roche, Pfizer, Bayer, Antares Pharma, Becton Dickinson, GlaxoSmithKline, Kindeva, Merck, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Drug Delivery Technologies Market Report Segments:
The global Drug Delivery Technologies market is segmented on the basis of:
Types
Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Home Care Settings, Clinics, Diagnostic Centres, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson Services
- Novartis
- Roche
- Pfizer
- Bayer
- Antares Pharma
- Becton Dickinson
- GlaxoSmithKline
- Kindeva
- Merck
- Sanofi
Highlights of The Drug Delivery Technologies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Drug Delivery
- Pulmonary Drug Delivery
- Injectable Drug Delivery
- Ocular Drug Delivery
- Nasal Drug Delivery
- Topical Drug Delivery
- Implantable Drug Delivery
- Transmucosal Drug Delivery
- By Application:
- Hospitals
- Home Care Settings
- Clinics
- Diagnostic Centres
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Delivery Technologies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug delivery technologies are methods used to administer drugs to patients. These technologies can be divided into two categories: oral and parenteral. Oral drug delivery includes methods such as tablets, capsules, and liquids that are taken by mouth. Parenteral drug delivery includes methods such as injections, infusions, and suppositories that are injected or inserted into the body through a vein.
Some of the major players in the drug delivery technologies market are Johnson & Johnson Services, Novartis, Roche, Pfizer, Bayer, Antares Pharma, Becton Dickinson, GlaxoSmithKline, Kindeva, Merck, Sanofi.
The drug delivery technologies market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Delivery Technologies Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Delivery Technologies Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Delivery Technologies Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Delivery Technologies Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Delivery Technologies Market Size & Forecast, 2020-2028
4.5.1 Drug Delivery Technologies Market Size and Y-o-Y Growth
4.5.2 Drug Delivery Technologies Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral Drug Delivery
5.2.2 Pulmonary Drug Delivery
5.2.3 Injectable Drug Delivery
5.2.4 Ocular Drug Delivery
5.2.5 Nasal Drug Delivery
5.2.6 Topical Drug Delivery
5.2.7 Implantable Drug Delivery
5.2.8 Transmucosal Drug Delivery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Home Care Settings
6.2.3 Clinics
6.2.4 Diagnostic Centres
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Delivery Technologies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Delivery Technologies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral Drug Delivery
9.6.2 Pulmonary Drug Delivery
9.6.3 Injectable Drug Delivery
9.6.4 Ocular Drug Delivery
9.6.5 Nasal Drug Delivery
9.6.6 Topical Drug Delivery
9.6.7 Implantable Drug Delivery
9.6.8 Transmucosal Drug Delivery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Home Care Settings
9.10.3 Clinics
9.10.4 Diagnostic Centres
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral Drug Delivery
10.6.2 Pulmonary Drug Delivery
10.6.3 Injectable Drug Delivery
10.6.4 Ocular Drug Delivery
10.6.5 Nasal Drug Delivery
10.6.6 Topical Drug Delivery
10.6.7 Implantable Drug Delivery
10.6.8 Transmucosal Drug Delivery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Home Care Settings
10.10.3 Clinics
10.10.4 Diagnostic Centres
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral Drug Delivery
11.6.2 Pulmonary Drug Delivery
11.6.3 Injectable Drug Delivery
11.6.4 Ocular Drug Delivery
11.6.5 Nasal Drug Delivery
11.6.6 Topical Drug Delivery
11.6.7 Implantable Drug Delivery
11.6.8 Transmucosal Drug Delivery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Home Care Settings
11.10.3 Clinics
11.10.4 Diagnostic Centres
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral Drug Delivery
12.6.2 Pulmonary Drug Delivery
12.6.3 Injectable Drug Delivery
12.6.4 Ocular Drug Delivery
12.6.5 Nasal Drug Delivery
12.6.6 Topical Drug Delivery
12.6.7 Implantable Drug Delivery
12.6.8 Transmucosal Drug Delivery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Home Care Settings
12.10.3 Clinics
12.10.4 Diagnostic Centres
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral Drug Delivery
13.6.2 Pulmonary Drug Delivery
13.6.3 Injectable Drug Delivery
13.6.4 Ocular Drug Delivery
13.6.5 Nasal Drug Delivery
13.6.6 Topical Drug Delivery
13.6.7 Implantable Drug Delivery
13.6.8 Transmucosal Drug Delivery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Home Care Settings
13.10.3 Clinics
13.10.4 Diagnostic Centres
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Delivery Technologies Market: Competitive Dashboard
14.2 Global Drug Delivery Technologies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson Services
14.3.2 Novartis
14.3.3 Roche
14.3.4 Pfizer
14.3.5 Bayer
14.3.6 Antares Pharma
14.3.7 Becton Dickinson
14.3.8 GlaxoSmithKline
14.3.9 Kindeva
14.3.10 Merck
14.3.11 Sanofi
